Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Opsens Inc V.OPS


Primary Symbol: T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Nadia6519on Apr 08, 2022 11:16am
91 Views
Post# 34587884

Found on TMX - Upcoming results - Next Wednesday

Found on TMX - Upcoming results - Next Wednesday

OPSENS TIENDRA UNE CONFERENCE TELEPHONIQUE SUR LES RESULTATS FINANCIERS DU SECOND TRIMESTRE DE L'EXERCICE 2022 MERCREDI LE 13 AVRIL

Canada Newswireavr. 6, 2022 9:00 AM EDT
La confrence tlphonique se tiendra 11 h HE

QUBEC le 6 avril 2022 /CNW Telbec/ -  OpSens inc. ( "OpSens" ou la "Socit") (TSX : OPS) (OTCQX : OPSSF), une socit spcialise en instrumentation mdicale en cardiologie offrant des solutions innovatrices bases sur sa technologie optique brevete, publiera les rsultats du deuxime trimestre de l'exercice 2022, termin le 28 fvrier, mercredi le 13 avril, avant l'ouverture du march. La Socit a prvu une confrence tlphonique le mme jour, 11h00, pour commenter les rsultats.

Les parties intresses peuvent accder la confrence tlphonique en composant le 1-833-756-0865 ou le 1-412-317-5754 ou peuvent l'couter en direct sur Internet, via la section Investisseurs du site de la Socit au https://opsens.com/fr/investisseurs/ ou au https://app.webinar.net/ABoWM6pRJ6q .

Une rediffusion de l'appel sera disponible via la section investisseurs du site Internet de la Socit au https://opsens.com/fr/investisseurs/ .

Prenez note que la confrence se tiendra en anglais.


<< Previous
Bullboard Posts
Next >>